Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation FGF_SIGNALING_PATHWAY_PID_NCI_NATURE_nonsilent_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-33743 | FGF_SIGNALING_PATHWAY | up-regulates | IRF2 | activates | R-424 | 25 | 5 | Drugs (4) |
CMF-33752 | FGF_SIGNALING_PATHWAY | up-regulates | IRF1 | activates | R-113 | 25 | 4 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)TAS0612, LANATOSIDE C, CEP-1347, DIGOXIN, ACETYLDIGITOXIN, OCRIPLASMIN, DIGITOXIN, DESLANOSIDE, ISTAROXIME |
CMF-33766 | FGF_SIGNALING_PATHWAY | up-regulates | STAT5B | activates | R-1544 | 9 | 3 | Drugs (16) Regulator Drugs (0)Regulon Drugs (16)BINTRAFUSP ALFA, TRILACICLIB, RIBOCICLIB, PALBOCICLIB, ABEMACICLIB, PHA-793887, LUSPATERCEPT, AZD-5438, RIBOCICLIB SUCCINATE, TRILACICLIB DIHYDROCHLORIDE, UCN-01, ALVOCIDIB, FRESOLIMUMAB, RONICICLIB, AT-7519, MARIMASTAT |